Both in Pharmaceuticals
Bausch Health Companies vs Dyne Therapeutics
Over the past year BHC returned +19.5% and DYN returned −25.1%; their daily moves had a correlation of 0.11.
BHC +19.5% DYN −25.1%Growth of $1, one year, split-adjusted
| Metric | BHC | DYN |
|---|---|---|
| Price | $8.14 | $18.05 |
| Market cap | $3.05B | $3.37B |
| Today | +1.50% | +4.34% |
| 1 month | +38.2% | +16.9% |
| 6 months | +44.3% | +3.3% |
| Year to date | +17.1% | −7.7% |
| 1 year | +16.0% | −20.1% |
| Revenue growth (YoY) | +9.7% | — |
| Gross margin | 75.0% | — |
| Net margin | 14.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | -$18.15B | $685.0M |
| Dividend yield | — | — |
| Volatility (60d) | 67.8% | 59.5% |
| Short % of float | 3.1% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).